Gene Query: AOX1

Dataset Description Geneva Score
GATA3-mediated chromatin reprogramming in breast cancer cells 120.92
Role of CD133 molecule in WNT response and renal repair 97.78
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 86.9
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 86.0
Expression by CD133+ cells isolated from the adult human exocrine pancreas 78.03
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 65.98
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 64.54
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 63.1
RNA expression following TMPRSS11B overexpression or depletion 60.36
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  59.85
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 55.93
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 55.93
PGE2 mediated gene expression changes in human cervical stromal cells 54.53
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 51.98
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 50.67
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 50.67
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 49.57
Single-nucleotide-resolution mapping of HBV promoters using CAGE 45.53
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 45.13
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 44.31
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 42.05
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 41.95
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 38.75
Nonpregnant and term pregnant human myometrial tissues 38.75
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 38.56
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 38.41
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 38.35
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 37.39
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 36.81
MCF10A H-Ras RNA-Seq 36.58
RNA-seq analyisis of PUM2 knockout cells 36.35
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 36.06
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 35.16
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 34.58
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 34.26
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 33.9
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 33.9
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 33.07
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 32.74
Generation of trichogenic adipose-derived stem cells by expression of three factors 32.58
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 32.44
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 32.21
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 31.81
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 31.66
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 31.58
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 31.17
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 31.14
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 31.14
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 30.94
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 30.23
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 30.23
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 30.22
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 28.86
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 28.86
Analysis of transcriptional regulation by Myt1 and Myt1l 28.57
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 28.22
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 28.22
RNA-Seq analysis of breast cancer cells after shikonin treatment 28.22
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 28.03
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 27.79
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 27.41
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 27.41
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 27.36
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 26.75
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 26.63
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 26.41
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 26.13
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 26.04
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 25.99
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  25.5
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 25.15
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 24.51
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 24.51
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 24.17
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 23.7
Human ovarian granulosa cell transcriptome 23.62
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 23.61
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 23.57
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 23.48
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 23.27
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 23.16
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 22.79
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 22.72
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 22.6
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 22.55
Overexpression of NFIB and YBX1 in MCF-7 cells 22.48
RNA-sequencing in immortalized human mammary epithelial cells 22.44
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 22.44
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 22.41
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 22.21
RNA sequencing of matched nephrectomy samples [RNA-seq] 22.21
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 22.18
MYCi975 regulates MYC target genes 22.05
Single cell transcriptome of peritoneal cells 22.04
Genome-wide identification of cancer-specific alternative splicing in circRNA 21.97
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 21.84
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 21.78
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 21.37
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 21.2
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 21.12
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 20.94
IRF2 is a master regulator of human keratinocyte stem cell fate 20.94
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 20.7
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 20.7
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 20.61
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 20.58
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 20.43
RNA sequencing of human mammary epithelial cells 20.41
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 20.23
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 20.16
The expression profiles of GBC liver metastasis 20.1
UBC9 knockdown in bladder cancer T24 cell lines 19.95
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 19.73
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 19.48
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 19.48
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 19.46
Disruption of the exocyst induces podocyte loss and dysfunction 19.39
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 19.33
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 19.18
Gene expression patterns define the hepatocyte-like cells derived by different strategies 18.68
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 18.68
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 18.43
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 18.28
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 18.18
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 18.16
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 17.95
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 17.93
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 17.93
Active translatome profiling with RiboLace in MCF7 cells 17.82
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 17.61
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 17.49
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 17.38
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 17.34
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 17.12
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 17.12
RNA-sequencing of formalin fixed human primary melanoma tissue 16.57
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 16.51
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 16.44
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 16.43
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 16.36
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 16.35
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 16.26
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 16.16
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 16.16
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 16.06
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 15.91
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 15.79
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 15.79
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 15.74
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 15.74
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 15.57
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 15.54
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 15.51
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 15.51
Effect of Hotair overexpression in human breast cancer cell lines 15.41
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 15.38
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 15.37
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 15.37
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 15.19
RNA-seq of MDA-MB-231 cells with TET1 knockout 15.1
Gene expression profile difference among renal location in a stone former 15.0
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 14.66
Expression patterns in chronic thromboembolic pulmonary hypertension 14.49
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 14.41
Toxoplasma gondii infection of human retinal pigment epithelial cells 14.31
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 14.22
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 14.22
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 14.15
RNA-seq of human aneuploid cell lines with Trisomy 21 14.0
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 13.92
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 13.91
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 13.89
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 13.72
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 13.72
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 13.68
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 13.56
Inhibition of TNBC metastasis by Gpx1 13.47
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 13.37
HNF1 regulates critical functions of the human epididymis epithelium. 13.37
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 13.3
Nucleoporin-mediated regulation of cell identity genes 13.27
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 13.23
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 13.14
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 13.04
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 13.04
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 12.55
RNA-seq of young and quiescent MRC-5 human fibroblasts 12.54
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 12.52
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 12.4
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 12.34
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 12.3
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 12.3
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 12.29
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 12.24
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 12.23
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 12.18
Endometrial transcriptome and PGR cistrome in cycling fertile women 12.17
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 12.17
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 12.12
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 11.96
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 11.94
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 11.93
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 11.87
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 11.87
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 11.79
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 11.78
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 11.72
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 11.63
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 11.56
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 11.52
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 11.49
Transcriptome analysis of U87 cells upon LINC00152 knockdown 11.34
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 11.32
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 11.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 11.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 11.32
EGR1-controlled transcriptome of T HESCs 11.19
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 11.15
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 11.15
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 11.13
Paxillin regulates genomic networks in prostate cancer [PC3] 11.0
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 10.87
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 10.82
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 10.61
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 10.57
Generation of KRAS signatures using immortalized isogenic lung cells. 10.54
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 10.52
iPSC-Derived Cholangiocytes 10.37
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 10.34
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 10.32
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 10.29
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 10.29
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 10.2
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 10.2
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 10.2
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 10.2
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 10.19
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 10.18
Random mono-allelic expression in MECP2-mutated cells 10.14
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 10.12
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 10.11
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 10.09
Investigation about fibroblasts of different origins in culture 10.03
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 10.0
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 9.81
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 9.78
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 9.75
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 9.75
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 9.66
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 9.58
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 9.58
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 9.56
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 9.52
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 9.48
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 9.45
Universal alternative splicing of noncoding exons 9.42
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.25
Cellular response to hepatitis E virus (HEV) infection 9.21
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 9.17
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 9.17
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.13
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 9.01
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 8.99
AUF-1 affected genes in human skin cells 8.91
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 8.74
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 8.61
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 8.61
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 8.54
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 8.5
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.5
IRF1 regulates IFN dependent and independent gene expression 8.47
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 8.31
The conserved transcriptional landscapes in human spermatogenesis 8.25
Fibroblasts in cholesteatoma activate osteoclasts. 8.21
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 8.19
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 8.12
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.08
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 7.97
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 7.95
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.95
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.95
Gene expression profile in breast cancer cells 7.93
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 7.93
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 7.89
A549 cell transcriptome responses to infection with H7N9 influenza virus 7.86
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 7.74
Loss of endometrial plasticity in recurrent pregnancy loss 7.68
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 7.68
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 7.55
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 7.49
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 7.47
Human islets of varying quality: the good, the (not so) bad and the ugly 7.42
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 7.4
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 7.4
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 7.37
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 7.29
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 7.22
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 7.21
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 7.21
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 7.19
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 7.14
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 7.13
Morphological and molecular characterization of human dermal lymphatic collectors 7.12
Changes in human endometrial gland transcriptome over the window of implantation 7.1
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 6.98
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.95
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 6.93
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 6.93
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 6.88
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 6.82
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 6.82
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 6.78
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 6.76
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 6.74
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 6.69
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 6.67
Neurofibroma 6.63
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 6.63
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 6.49
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 6.47
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 6.47
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 6.47
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 6.36
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 6.36
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 6.3
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.23
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 6.21
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 6.2
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 6.12
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 6.04
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 6.04
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.04
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.04
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 5.97
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 5.97
Gene expression of collecting duct carcinoma of the kidney 5.97
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 5.86
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 5.86
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 5.86
Redifferentiation of expanded human islet β cells by inhibition of ARX 5.85
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 5.84
RNA-seq analysis upon ARID1B overexpression 5.77
High-efficiency RNA-based reprogramming of human primary fibroblasts 5.71
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 5.68
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 5.56
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 5.56
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 5.51
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 5.51
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 5.45
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 5.35
The cohesin complex prevents Myc-induced replication stress 5.31
In vitro modeling of human germ cell development using pluripotent stem cells 5.29
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 5.16
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 5.05
PTHrP overexpression in MCF7 cells 5.04
Gene expression of thyroid cancer cell lines 5.03
Gene expression changes in human melanoma cell lines compared to primary melanocytes 5.01
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 4.97
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 4.95
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 4.95
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 4.92
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 4.92
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.87
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 4.85
RNA-Seq of Breast and Ovarian Cancer Cell Lines 4.82
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 4.8
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 4.8
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 4.77
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 4.72
Hepatocyte maturation 4.67
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.59
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 4.58
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.52
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.52
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 4.49
Effects of transcription on genome - nuclear lamina interactions 4.49
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.46
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 4.39
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 4.39
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.32
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.27
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.27
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 4.25
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 4.22
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 4.15
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 4.12
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 4.03
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 3.98
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.97
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 3.9
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.89
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 3.77
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 3.72
Transcriptome of human white and brown adipose tissue biopsies 3.65
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.64
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 3.61
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 3.61
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.55
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 3.42
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.35
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 3.34
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 3.28
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 3.27
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.19
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.19
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 3.14
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.12
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.11
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.11
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 3.08
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 3.06
Transcriptome analysis reveals differential splicing events in IPF lung tissue 3.0
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.82
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.82
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.77
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 2.75
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 2.75
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 2.75
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 2.73
Identification of expressed and conserved human non-coding RNAs 2.7
The circadian transcriptional landscape in primary human mammary epithelial cells 2.68
Gene expression analysis in response to hypoxic pathway inhibition 2.68
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 2.62
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 2.61
Molecular analysis of renal cell carcinoma with unclassfied histology 2.53
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.53
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.48
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.47
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 2.43
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.39
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.37
RNAseq analysis of ruxolitinib treated breast cancers 2.32
Repurposing of promoters and enhancers during mammalian evolution 2.29
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 2.29
Deep RNA sequencing of the human placental transcriptome 2.28
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.27
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 2.24
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.23
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 2.23
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 2.22
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 2.22
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.16
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 2.14
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 2.09
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.98
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.97
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.92
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.92
CHD1 regulates cell fate determination by activation of differentiation-induced genes 1.92
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 1.91
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.89
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.89
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.74
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.73
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 1.63
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.63
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.63
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.63
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.6
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.5
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 1.37
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 1.37
RNA Seq of Alagille liver biopsies 1.34
Alagille_Nodder 1.34
RNA seq_PDX2_SHP099 1.32
Hepatic transcriptome of pediatric hepatoblastoma. 1.3
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.28
p53 activity results in DNA replication fork processivity 1.24
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 1.14
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 1.07
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.99
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.92
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.88
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.75
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.75
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.64
BMS-470539 on human synovial fibroblasts 0.63
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.51
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.5
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.47
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.47
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.43
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 0.33
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.33
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.33
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.27
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.27
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.26
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.26
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.2
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 0.18
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 0.18
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.18
RNA-Seq and expression data from human adipose tissue 0.18
Regulation of hypoxia-inducible factor activity by ZMYND8 0.17
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.14
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.13
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.1
Investigate A2M treatment on human prostate cancer xenograft in mice 0.06
Investigate A2M treatment on human prostate cancer and mouse liver 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation